Document is current

Any future updates will be listed below

MET tyrosine kinase inhibitors in combination with EGFR tyrosine kinase inhibitors in NSCLC patients with EGFR mutations and acquired MET alterations: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12885-025-14145-5

Published Online: 2025-04-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark